USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-25 обновлены отчеты компании LXRX: 202320222021
Lexicon Pharmaceuticals logo
Lexicon Pharmaceuticals LXRX
$ 1.58 2.6%

Lexicon Pharmaceuticals Мультипликаторы 2011-2024 | LXRX

Мультипликаторы по годам Lexicon Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.6 -4.5 -6.5 - 2.6 -3.9 -9.0 -10.0 -225.5 -4.8 -9.0 -9.4 -4.4

P/S

389.4 3278.9 1925.7 - 1.1 7.4 12.9 17.0 8.1 21.3 422.6 948.8 274.6

EPS

-0.8 -0.6 -0.6 -0.5 1.2 -1.1 -1.2 -1.4 -0.1 -0.2 -0.2 -0.2 -0.3

EV (Enterprise Value)

583 млн 487 млн 533 млн -78.8 млн 604 млн 697 млн 1.48 млрд 1.69 млрд 1.22 млрд 536 млн 1.01 млрд 1.11 млрд 454 млн

EBITDA per Share

-0.77 -0.61 -0.6 - 1.64 -0.941 -1.25 -1.31 0.113 -1.1 -1.39 -1.35 -2.24

EV/EBITDA

0.5 -4.4 3.2 -6.3 -10.3 -10.9 81.8 -5.4 -9.1 -10.9 -3.2

PEG

- 0.1 0.01 -0.53 -0.94 0.0 -2.34 -0.97 -0.69 -0.29 -1.63

P/B

5.0 3.9 5.1 - 2.9 -17.7 22.3 9.0 3.7 1.7 5.5 3.9 1.7

P/CF

-2.9 -5.1 -6.6 - 3.0 -3.1 -6.3 -8.1 5.7 -6.4 -10.1 -10.9 -5.7

ROE %

-190.23 -87.04 -77.26 -37.46 111.13 456.53 -247.69 -89.85 -1.64 -35.31 -61.19 -41.33 -39.05

ROA %

-77.20 -52.47 -64.10 -28.74 31.15 -42.43 -29.56 -29.74 -0.71 -21.28 -37.98 -29.64 -26.99

ROCE %

-184.46 -86.03 -76.67 -30.57 48.27 -41.75 -43.08 -44.33 2.07 -20.13 -41.03 -27.87 -27.89

Current Ratio

1.7 2.5 5.9 4.3 5.2 4.7 2.6 2.2 4.3 8.2 7.0 12.6 13.4

DSO

157.3 55.1 250.5 433.0 64.1 34.2 19.5 32.8 2.6 16.5 129.8 461.9 69.1

DIO

818.0 - - 401.4 479.3 685.7 374.4 - - - - - -

DPO

53212.7 - - 1669.6 1375.7 2602.2 11081.1 - - - - - -

Операционный цикл

975.4 55.1 250.5 834.4 543.4 720.0 393.9 - - - - - -

Финансовый цикл

-52237.3 55.1 250.5 -835.2 -832.3 -1882.2 -10687.2 - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Lexicon Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.21 -0.22 -0.17 - -0.13 -0.16 -0.16 - -0.16 -0.13 -0.15 - 0.77 -0.65 -0.63 -0.48 2.13 -0.22 -0.42 -0.16 -0.26 -0.33 -0.4 -0.25 -0.29 -0.33 -0.33 -0.31 -0.35 -0.37 -0.34 0.84 -0.34 -0.27 -0.27 -0.03 -0.55 -0.35 -0.06 -0.03 -0.06 -0.06 -0.05 -0.05 -0.06 -0.05 -0.06 -0.1 -0.08 -0.08 -0.09

EBITDA per Share

- - -0.16 - -0.13 -0.16 -0.16 - -0.16 -0.12 -0.15 - 0.83 -0.59 -0.58 - 2.14 -0.17 -0.32 -0.12 -0.19 -0.27 -0.35 -0.27 -0.25 -0.3 -0.37 -0.3 -0.32 -0.35 -0.32 0.85 -0.32 -0.25 -0.25 -0.04 -0.53 -0.34 -0.06 -0.03 -0.06 -0.05 -0.05 -0.05 -0.05 -0.05 -0.06 -0.1 -0.06 -0.07 -0.08

ROE %

-112.82 -92.84 -103.46 -76.28 -93.20 -93.89 -72.34 -43.83 8.99 78.75 47.74 -33.94 -77.61 62.63 142.28 146.60 253.83 164.51 259.88 456.53 354.00 193.03 -4.33 -223.97 -204.34 -170.01 -127.71 -88.61 -38.92 -28.38 -13.99 -1.65 -33.02 -34.93 -34.28 -35.31 -44.51 -48.86 -56.78 -61.19 -60.29 -52.76 -45.39 -41.33 -43.37 -41.07 -40.30 -39.05 -8.77 -8.95 -9.96

ROA %

-64.28 -58.20 -61.27 -46.68 -60.10 -44.07 -54.60 -34.79 5.75 59.70 36.33 -26.05 -38.29 -24.70 -0.68 21.28 27.62 -36.15 -38.44 -42.43 -42.62 -39.80 -35.58 -28.17 -28.90 -29.64 -29.71 -29.74 -9.61 -7.45 -3.75 -0.72 -14.65 -17.83 -19.04 -21.28 -27.01 -29.96 -35.05 -37.98 -38.32 -34.72 -31.08 -29.64 -30.82 -28.93 -28.15 -26.99 -6.06 -6.19 -6.88

ROCE %

-110.72 -91.18 -101.34 -75.15 -91.96 -92.73 -71.93 -43.56 11.87 84.11 55.90 -25.80 -66.12 70.32 140.20 149.37 236.53 131.49 217.55 391.13 301.79 160.06 -18.86 -237.52 -213.72 -181.01 -140.25 -85.94 -36.33 -25.92 -11.74 0.50 -31.61 -34.03 -33.89 -35.34 -44.10 -48.24 -55.87 -60.16 -59.37 -51.92 -44.65 -40.65 -42.67 -40.41 -39.57 -38.34 -8.63 -8.71 -9.79

Current Ratio

2.0 2.4 2.2 2.5 4.0 - 3.1 5.9 4.8 5.0 4.8 4.3 4.3 4.3 4.3 1.4 1.4 0.8 1.4 0.9 0.9 0.9 0.9 1.2 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.8 1.8 1.8 1.8 2.5 2.5 2.5 2.5 2.6 2.6 2.6 2.6 3.5 3.5 3.5 3.5 3.2 3.2 3.2 3.2

DSO

282.5 136.2 - - 45.6 48.2 - - 361.0 50.7 838.1 - 5.4 3.9 324.7 591.1 9.6 292.7 150.8 31.7 77.6 39.2 19.3 13.3 16.3 36.5 30.7 29.7 24.7 34.0 30.7 0.7 146.9 221.1 49.5 4.4 225.4 139.7 300.6 51.1 302.9 336.9 274.8 576.8 338.0 631.9 262.8 93.1 90.0 57.5 -

DIO

3311.1 - - - - - - - - - - - 287.5 509.9 673.9 - 673.7 292.9 216.6 - 775.0 509.6 567.4 - 296.8 331.0 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

146893.0 118693.4 - - - - - - - - - - 788.4 685.5 1417.5 - 1755.9 763.5 588.0 - 2941.0 1933.8 4838.2 - 8782.5 9796.5 - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

3593.6 136.2 - - 45.6 48.2 - - 361.0 50.7 838.1 - 292.9 513.8 998.6 591.1 683.3 585.6 367.3 31.7 852.6 548.8 586.7 13.3 313.1 367.5 30.7 29.7 24.7 34.0 30.7 0.7 146.9 221.1 49.5 4.4 225.4 139.7 300.6 51.1 302.9 336.9 274.8 576.8 338.0 631.9 262.8 93.1 90.0 57.5 -

Финансовый цикл

-143299.4 -118557.3 - - 45.6 48.2 - - 361.0 50.7 838.1 - -495.4 -171.7 -418.9 591.1 -1072.6 -177.9 -220.7 31.7 -2088.4 -1385.0 -4251.5 13.3 -8469.5 -9429.0 30.7 29.7 24.7 34.0 30.7 0.7 146.9 221.1 49.5 4.4 225.4 139.7 300.6 51.1 302.9 336.9 274.8 576.8 338.0 631.9 262.8 93.1 90.0 57.5 -

Все данные представлены в валюте USD